Albion Investors
Albion Investors LLC, established in 1995 and headquartered in New York, is a private investment firm managing funds for institutional and family-office investors. It specializes in private equity and debt investments, focusing on lower middle-market companies. Albion invests in value-added distribution, specialty manufacturing, and business services sectors, typically committing between $3 million to $30 million in equity and debt. The firm seeks lead positions in micro-cap deals and co-investment opportunities, with a focus on companies in the Mid-Atlantic, North-East, and South-East regions of the Continental United States and Canada. Albion's principals invest their own capital in every lead transaction. The firm's primary investment vehicle is a mezzanine note, combining subordinated debt and equity participation. Albion aims to take majority or minority stakes and board seats in its portfolio companies.
Helveta
Venture Round in 2010
Helveta Ltd develops technology products for the timber and food sectors. It offers The CI World platform, an interactive cartography application that provides auditable traceability, asset tracking, resource and forest use mapping, and chain of custody control for extended supply chains; and allows monitoring logging activities, and to export data points and associated icons to GIS products enabling the online sharing of maps among communities over the Web. The company serves growers, farm managers, agronomists, and buyers. Helveta Ltd was incorporated in 2004 and is based in Oxford, the United Kingdom with operations in Nigeria, the Central African Republic, the Republic of Congo, and Cameroon.
Xceleron
Venture Round in 2010
Xceleron, founded in 1997 in York, UK, and now based in Germantown, Maryland, specializes in bioanalytical accelerator mass spectrometry (AMS) services to enhance drug development. The company pioneered techniques for human microdosing and microtracing, focusing on the pharmacokinetics and metabolism of developmental drugs during early clinical trial phases. Xceleron's services include micro-dosing, preclinical evaluation, intravenous pharmacokinetics, metabolite profiling, and mass balance investigations in humans. Their expertise is particularly valuable given the complexity of modern small molecules, which often exhibit low solubility and lengthy half-lives, necessitating early pharmacokinetic characterization to improve the cost-effectiveness of clinical development. Through a commitment to integrity and collaboration, Xceleron aims to accelerate the delivery of life-changing products to the market.
Osterman Propane
Series C in 2008
Osterman Propane is a provider of propane gas utilities catering to residential, commercial, and industrial clients. Founded in New England, the company has a legacy of over fifty years in delivering efficient propane gas and heating services. It was formed from the merger of Bay State Propane and Northern Propane, both of which were longstanding affiliates of Bay State Gas and Northern Utilities. Osterman Propane focuses on delivering quality services at competitive prices, ensuring that its clients receive reliable energy solutions tailored to their needs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.